AN2718 + AN2718 + AN2718 + AN2718 + AN2718 + AN2718

Phase 1Completed

0 watching 0 views this week💤 Quiet

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Tinea Pedis

Conditions

Tinea Pedis

Trial Timeline

Oct 1, 2008 → Nov 1, 2008

NCT ID

NCT00781664

About AN2718 + AN2718 + AN2718 + AN2718 + AN2718 + AN2718

AN2718 + AN2718 + AN2718 + AN2718 + AN2718 + AN2718 is a phase 1 stage product being developed by Pfizer for Tinea Pedis. The current trial status is completed. This product is registered under clinical trial identifier NCT00781664. Target conditions include Tinea Pedis.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00781664	Phase 1	Completed	Oct 1, 2008	Nov 1, 2008	Tinea Pedis

Competing Products

20 competing products in Tinea Pedis

See all competitors

Product	Company	Stage	Hype Score
Butenafine Hydrochloride 1% + Butenafine Hydrochloride 1% B + Butenafine Hydrochloride 1% + Vehicle A + Vehicle B	Sun Pharmaceutical	Phase 1	33
Naftifine Hydrochloride Gel 2% + Naftin® Gel 2% + Placebo Topical Gel	Sun Pharmaceutical	Phase 1	33
Naftifine Hydrochloride Cream 2% + Naftin® (Naftifine Hydrochloride) Cream 2% + Placebo Topical Cream	Sun Pharmaceutical	Phase 1	33
Butenafine Hydrochloride Cream, 1% + Lotrimin Ultra® + Butenafine Vehicle	Sun Pharmaceutical	Phase 1	33
Naftifine HCl Cream 1% + Naftin® (Naftifine HCl) Cream 1% + Placebo topical cream	Sun Pharmaceutical	Phase 1	33
Ketoconazole Shampoo, 2% + Ketoconazole Shampoo, 2% (Reference Standard) + Placebo	Sun Pharmaceutical	Phase 1	33
TA103 + Placebo Control	Sun Pharmaceutical	Phase 1	33
Oxiconazole Nitrate Cream 1% + Oxiconazole Nitrate Cream 1% (Oxistat®) + Placebo	Sun Pharmaceutical	Phase 1	33
Butenafine cream 1% manufactured by Taro + Lotrimin Ultra (butenafine) 1% + Butenafine Vehicle manufactured by Taro	Sun Pharmaceutical	Phase 1	33
Sertaconazole nitrate cream 2%	Johnson & Johnson	Phase 3	77
Placebo cream + Ketoconazole 2% cream (formulation F012) (Nizoral) + Ketoconazole 2% cream (formulation F126)	Johnson & Johnson	Phase 3	77
Terbinafine hydrochloride (HCl) + Griseofulvin	Novartis	Phase 3	77
Terbinafine + Terbinafine Placebo	Novartis	Phase 3	77
Terbinafine hydrochloride	Novartis	Phase 3	77
fluconazole	Pfizer	Phase 3	76
W0027 + Placebo	GSK plc	Phase 1	32
Bifonazole spray once daily + Bifonazole spray twice daily + Placebo + Placebo + Lamisil Once	Bayer	Phase 2	49
Econazole Nitrate Cream, 1% + Placebo	Viatris	Phase 3	74
LAS41003 + LAS189961 + LAS189962	Almirall	Phase 2	47
Luliconazole Cream 1% + Vehicle Cream	Bausch Health	Approved	80

Other Products from Pfizer